172 related articles for article (PubMed ID: 34544358)
1. Inhibitory immune checkpoints PDCD-1 and LAG-3 hypermethylation may reduce the risk of colorectal cancer.
Zhang Y; Zhang L; Sun H; Liu Y; Xu J; Huang H; Fu J; Zhang D; Tian T; Zhao Y; Wang G
Mol Med; 2021 Sep; 27(1):114. PubMed ID: 34544358
[TBL] [Abstract][Full Text] [Related]
2. DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer.
Sasidharan Nair V; Toor SM; Taha RZ; Shaath H; Elkord E
Clin Epigenetics; 2018 Aug; 10(1):104. PubMed ID: 30081950
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer.
Sasidharan Nair V; El Salhat H; Taha RZ; John A; Ali BR; Elkord E
Clin Epigenetics; 2018; 10():78. PubMed ID: 29983831
[TBL] [Abstract][Full Text] [Related]
4. Identifying CpG sites with different differential methylation frequencies in colorectal cancer tissues based on individualized differential methylation analysis.
Yan H; He J; Guan Q; Cai H; Zhang L; Zheng W; Qi L; Zhang S; Liu H; Li H; Zhao W; Yang S; Guo Z
Oncotarget; 2017 Jul; 8(29):47356-47364. PubMed ID: 28537885
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
Zhang H; Dong S; Feng J
J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
[TBL] [Abstract][Full Text] [Related]
6. Aging related methylation influences the gene expression of key control genes in colorectal cancer and adenoma.
Galamb O; Kalmár A; Barták BK; Patai ÁV; Leiszter K; Péterfia B; Wichmann B; Valcz G; Veres G; Tulassay Z; Molnár B
World J Gastroenterol; 2016 Dec; 22(47):10325-10340. PubMed ID: 28058013
[TBL] [Abstract][Full Text] [Related]
7. Methylation Status of Transcriptional Modulatory Genes Associated with Colorectal Cancer in Northeast China.
Gao HL; Wang X; Sun HR; Zhou JD; Lin SQ; Xing YH; Zhu L; Zhou HB; Zhao YS; Chi Q; Liu YP
Gut Liver; 2018 Mar; 12(2):173-182. PubMed ID: 29291617
[TBL] [Abstract][Full Text] [Related]
8. Relationship between immune checkpoint proteins, tumour microenvironment characteristics, and prognosis in primary operable colorectal cancer.
Al-Badran SS; Grant L; Campo MV; Inthagard J; Pennel K; Quinn J; Konanahalli P; Hayman L; Horgan PG; McMillan DC; Roxburgh CS; Roseweir A; Park JH; Edwards J
J Pathol Clin Res; 2021 Mar; 7(2):121-134. PubMed ID: 33338327
[TBL] [Abstract][Full Text] [Related]
9. Methylation of a panel of genes in peripheral blood leukocytes is associated with colorectal cancer.
Luo X; Huang R; Sun H; Liu Y; Bi H; Li J; Yu H; Sun J; Lin S; Cui B; Zhao Y
Sci Rep; 2016 Jul; 6():29922. PubMed ID: 27453436
[TBL] [Abstract][Full Text] [Related]
10. Lack of Association Between
Lin J; Chen H; Huang Y; Tang W; Zhang S; Chen Y
Immunol Invest; 2022 Aug; 51(6):1867-1882. PubMed ID: 35499255
[TBL] [Abstract][Full Text] [Related]
11. CHST7 Gene Methylation and Sex-Specific Effects on Colorectal Cancer Risk.
Bi H; Liu Y; Pu R; Xia T; Sun H; Huang H; Zhang L; Zhang Y; Liu Y; Xu J; Rong J; Zhao Y
Dig Dis Sci; 2019 Aug; 64(8):2158-2166. PubMed ID: 30815821
[TBL] [Abstract][Full Text] [Related]
12. Integrative Analysis of DNA Methylation and Gene Expression Profiles Identifies Colorectal Cancer-Related Diagnostic Biomarkers.
Xu M; Yuan L; Wang Y; Chen S; Zhang L; Zhang X
Pathol Oncol Res; 2021; 27():1609784. PubMed ID: 34366718
[No Abstract] [Full Text] [Related]
13. Aberrant methylation of ERBB pathway genes in sporadic colorectal cancer.
Szmida E; Karpiński P; Leszczynski P; Sedziak T; Kielan W; Ostasiewicz P; Sasiadek MM
J Appl Genet; 2015 May; 56(2):185-92. PubMed ID: 25366420
[TBL] [Abstract][Full Text] [Related]
14. The hypermethylation of p16 gene exon 1 and exon 2: potential biomarkers for colorectal cancer and are associated with cancer pathological staging.
Ye X; Mo M; Xu S; Yang Q; Wu M; Zhang J; Chen B; Li J; Zhong Y; Huang Q; Cai C
BMC Cancer; 2018 Oct; 18(1):1023. PubMed ID: 30348132
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of Immune Checkpoints HLA-G/ILT-2/4 and PD-L1 in Colorectal Cancer.
Chen QY; Chen YX; Han QY; Zhang JG; Zhou WJ; Zhang X; Ye YH; Yan WH; Lin A
Front Immunol; 2021; 12():679090. PubMed ID: 34054869
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
[TBL] [Abstract][Full Text] [Related]
17. Aberrant Methylation of FOXE1 Contributes to a Poor Prognosis for Patients with Colorectal Cancer.
Sugimachi K; Matsumura T; Shimamura T; Hirata H; Uchi R; Ueda M; Sakimura S; Iguchi T; Eguchi H; Masuda T; Morita K; Takenaka K; Maehara Y; Mori M; Mimori K
Ann Surg Oncol; 2016 Nov; 23(12):3948-3955. PubMed ID: 27271927
[TBL] [Abstract][Full Text] [Related]
18. Epigenomic analysis of aberrantly methylated genes in colorectal cancer identifies genes commonly affected by epigenetic alterations.
Kim YH; Lee HC; Kim SY; Yeom YI; Ryu KJ; Min BH; Kim DH; Son HJ; Rhee PL; Kim JJ; Rhee JC; Kim HC; Chun HK; Grady WM; Kim YS
Ann Surg Oncol; 2011 Aug; 18(8):2338-47. PubMed ID: 21298349
[TBL] [Abstract][Full Text] [Related]
19. A panel of DNA methylation signature from peripheral blood may predict colorectal cancer susceptibility.
Onwuka JU; Li D; Liu Y; Huang H; Xu J; Liu Y; Zhang Y; Zhao Y
BMC Cancer; 2020 Jul; 20(1):692. PubMed ID: 32711505
[TBL] [Abstract][Full Text] [Related]
20. Impact of catechol-O-methyltransferase gene variants on methylation status of P16 and MGMT genes and their downregulation in colorectal cancer.
Wani HA; Majid S; Bhat AA; Amin S; Farooq R; Bhat SA; Naikoo NA; Beigh MA; Kadla SA
Eur J Cancer Prev; 2019 Mar; 28(2):68-75. PubMed ID: 30379684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
